S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bitcoin Group SE stock logo
BTGGF
Bitcoin Group
$58.40
$49.56
$19.50
$59.76
$22.57B0.26175 shs13 shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$382.44
-0.7%
$393.75
$185.43
$419.42
$11.93B1.38169,197 shs212,271 shs
National Research Co. stock logo
NRC
National Research
$33.32
-3.0%
$38.76
$33.25
$47.25
$819.64M0.4250,367 shs41,923 shs
Syneos Health, Inc. stock logo
SYNH
Syneos Health
$42.98
+0.0%
$42.86
$22.89
$52.23
$4.46B1.581.92 million shs7.39 million shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bitcoin Group SE stock logo
BTGGF
Bitcoin Group
0.00%+5.43%-2.28%+31.35%+108.80%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
-0.68%-3.84%-2.17%+31.19%+99.52%
National Research Co. stock logo
NRC
National Research
-3.03%-5.90%-16.22%-15.73%-24.00%
Syneos Health, Inc. stock logo
SYNH
Syneos Health
0.00%0.00%0.00%0.00%+6.68%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bitcoin Group SE stock logo
BTGGF
Bitcoin Group
N/AN/AN/AN/AN/AN/AN/AN/A
Medpace Holdings, Inc. stock logo
MEDP
Medpace
4.4705 of 5 stars
1.44.00.04.62.74.23.1
National Research Co. stock logo
NRC
National Research
0.7672 of 5 stars
0.03.01.70.01.70.81.3
Syneos Health, Inc. stock logo
SYNH
Syneos Health
0.4807 of 5 stars
1.00.00.04.50.61.71.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bitcoin Group SE stock logo
BTGGF
Bitcoin Group
N/AN/AN/AN/A
Medpace Holdings, Inc. stock logo
MEDP
Medpace
2.75
Moderate Buy$382.00-0.12% Downside
National Research Co. stock logo
NRC
National Research
N/AN/AN/AN/A
Syneos Health, Inc. stock logo
SYNH
Syneos Health
2.00
Hold$43.000.05% Upside

Current Analyst Ratings

Latest MEDP, BTGGF, NRC, and SYNH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/18/2024
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageHold$395.00
2/15/2024
Medpace Holdings, Inc. stock logo
MEDP
Medpace
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$282.00 ➝ $452.00
2/14/2024
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$312.00 ➝ $408.00
(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bitcoin Group SE stock logo
BTGGF
Bitcoin Group
N/AN/AN/AN/AN/AN/A
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$1.89B6.28$10.01 per share38.22$18.22 per share20.99
National Research Co. stock logo
NRC
National Research
$148.58M5.35$1.48 per share22.57$2.02 per share16.50
Syneos Health, Inc. stock logo
SYNH
Syneos Health
$5.39B0.83$6.72 per share6.40$33.96 per share1.27

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bitcoin Group SE stock logo
BTGGF
Bitcoin Group
N/AN/A0.00N/AN/AN/AN/AN/A
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$282.81M$8.8843.0730.042.0315.00%63.98%19.02%4/22/2024 (Confirmed)
National Research Co. stock logo
NRC
National Research
$30.97M$1.2526.66N/A20.84%47.79%24.27%5/7/2024 (Estimated)
Syneos Health, Inc. stock logo
SYNH
Syneos Health
$266.50M$0.6962.29N/A1.31%8.63%3.66%N/A

Latest MEDP, BTGGF, NRC, and SYNH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/22/2024N/A
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$2.45N/A-$2.45N/AN/AN/A  
2/13/2024Q4 2023
National Research Co. stock logo
NRC
National Research
N/A$0.36+$0.36$0.36N/A$38.00 million
2/12/202412/31/2023
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$2.22$2.46+$0.24$2.46$498.72 million$498.40 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bitcoin Group SE stock logo
BTGGF
Bitcoin Group
N/AN/AN/AN/AN/A
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/AN/AN/AN/AN/A
National Research Co. stock logo
NRC
National Research
$0.481.44%+31.73%38.40%N/A
Syneos Health, Inc. stock logo
SYNH
Syneos Health
N/AN/AN/AN/AN/A

Latest MEDP, BTGGF, NRC, and SYNH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/13/2024
National Research Co. stock logo
NRC
National Research
Quarterly$0.121.2%3/27/20243/29/20244/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bitcoin Group SE stock logo
BTGGF
Bitcoin Group
N/AN/AN/A
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/A
0.64
0.64
National Research Co. stock logo
NRC
National Research
0.60
0.67
0.67
Syneos Health, Inc. stock logo
SYNH
Syneos Health
0.77
1.20
1.20

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bitcoin Group SE stock logo
BTGGF
Bitcoin Group
N/A
Medpace Holdings, Inc. stock logo
MEDP
Medpace
77.98%
National Research Co. stock logo
NRC
National Research
47.26%
Syneos Health, Inc. stock logo
SYNH
Syneos Health
91.16%

Insider Ownership

CompanyInsider Ownership
Bitcoin Group SE stock logo
BTGGF
Bitcoin Group
N/A
Medpace Holdings, Inc. stock logo
MEDP
Medpace
20.30%
National Research Co. stock logo
NRC
National Research
2.00%
Syneos Health, Inc. stock logo
SYNH
Syneos Health
0.34%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bitcoin Group SE stock logo
BTGGF
Bitcoin Group
35386.49 millionN/ANot Optionable
Medpace Holdings, Inc. stock logo
MEDP
Medpace
5,90030.98 million24.69 millionOptionable
National Research Co. stock logo
NRC
National Research
43523.85 million23.38 millionOptionable
Syneos Health, Inc. stock logo
SYNH
Syneos Health
28,768103.72 million103.37 millionOptionable

MEDP, BTGGF, NRC, and SYNH Headlines

SourceHeadline
Marcie Doser to lead influencer marketing for Syneos Health US PRMarcie Doser to lead influencer marketing for Syneos Health US PR
mmm-online.com - April 3 at 4:43 PM
A conversation with the Value & Access team at Syneos HealthA conversation with the Value & Access team at Syneos Health
mmm-online.com - March 18 at 2:31 PM
Syneos Health leaves state jobs deal, months after the Morrisville company goes privateSyneos Health leaves state jobs deal, months after the Morrisville company goes private
newsobserver.com - February 29 at 3:20 PM
Syneos Health cancels hiring goals linked to Morrisville HQSyneos Health cancels hiring goals linked to Morrisville HQ
bizjournals.com - February 28 at 11:58 PM
People to Watch in 2024: Syneos Health CEO Colin ShannonPeople to Watch in 2024: Syneos Health CEO Colin Shannon
bizjournals.com - January 12 at 9:24 AM
Syneos Health Releases 2024 Dealmakers Intentions SurveySyneos Health Releases 2024 Dealmakers' Intentions Survey
finance.yahoo.com - January 9 at 8:24 AM
Crossject engages Syneos Health for U.S. commercial launch of ZEPIZURE®Crossject engages Syneos Health for U.S. commercial launch of ZEPIZURE®
markets.businessinsider.com - January 4 at 2:06 PM
2023 Year in Review: Syneos Health seeks turnaround after $7B deal to go private2023 Year in Review: Syneos Health seeks turnaround after $7B deal to go private
bizjournals.com - December 29 at 9:50 AM
Syneos Health Releases 2024 Health TrendsSyneos Health Releases 2024 Health Trends
finance.yahoo.com - December 20 at 3:07 PM
Syneos Health Appoints Colin Shannon as CEOSyneos Health Appoints Colin Shannon as CEO
pharmexec.com - October 4 at 3:09 PM
Syneos Health Appoints Colin Shannon as Chief Executive OfficerSyneos Health Appoints Colin Shannon as Chief Executive Officer
tmcnet.com - October 3 at 1:12 PM
Days after closing PE buyout, Syneos Health names Colin Shannon as CEODays after closing PE buyout, Syneos Health names Colin Shannon as CEO
mmm-online.com - October 3 at 1:12 PM
Syneos Health Appoints Colin Shannon To Succeed Michelle Keefe As CEOSyneos Health Appoints Colin Shannon To Succeed Michelle Keefe As CEO
markets.businessinsider.com - October 3 at 1:12 PM
SYNH Syneos Health, Inc.SYNH Syneos Health, Inc.
seekingalpha.com - October 2 at 8:45 PM
Syneos Health goes private after private equity deals; execs land more than $50MSyneos Health goes private after private equity deals; execs land more than $50M
wraltechwire.com - September 29 at 1:21 PM
Syneos Health execs in line for huge payouts with $7B buyoutSyneos Health execs in line for huge payouts with $7B buyout
finance.yahoo.com - September 28 at 7:45 PM
It’s official: Syneos Health goes private in $7.1B PE dealIt’s official: Syneos Health goes private in $7.1B PE deal
mmm-online.com - September 28 at 2:41 PM
Syneos Health Closes Transaction with Private Investment FirmsSyneos Health Closes Transaction with Private Investment Firms
finance.yahoo.com - September 28 at 2:41 PM
Checking in on Syneos Health Inc (SYNH) after recent insiders movementChecking in on Syneos Health Inc (SYNH) after recent insiders movement
knoxdaily.com - September 27 at 6:35 PM
S&P Dow Jones Indices: Civitas Resources Set to Join S&P MidCap 400; Hayward Holdings to Join S&P SmallCap 600S&P Dow Jones Indices: Civitas Resources Set to Join S&P MidCap 400; Hayward Holdings to Join S&P SmallCap 600
finanznachrichten.de - September 27 at 8:34 AM
Syneos Health Names Terttu Haring President, Clinical Sites & PatientsSyneos Health Names Terttu Haring President, Clinical Sites & Patients
finance.yahoo.com - September 26 at 9:35 AM
Syneos Deadline AlertSyneos Deadline Alert
stockhouse.com - September 25 at 9:28 AM
SYNEOS 72 HOUR DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Syneos To Contact Him Directly To Discuss Their OptionsSYNEOS 72 HOUR DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Syneos To Contact Him Directly To Discuss Their Options
prnewswire.com - September 23 at 11:01 AM
SYNEOS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Syneos Health, Inc. and Encourages Investors to Contact ...SYNEOS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Syneos Health, Inc. and Encourages Investors to Contact ...
businesswire.com - September 23 at 9:27 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Bitcoin Group logo

Bitcoin Group

OTCMKTS:BTGGF
Bitcoin Group SE, an investment holding company, engages in the cryptocurrency and blockchain businesses worldwide. The company operates a trading platform for the digital currency bitcoin under the Bitcoin.de. It also provides financial services. The company was founded in 2008 and is based in Herford, Germany. Bitcoin Group SE is a subsidiary of Priority AG.
Medpace logo

Medpace

NASDAQ:MEDP
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
National Research logo

National Research

NASDAQ:NRC
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
Syneos Health logo

Syneos Health

NASDAQ:SYNH
Syneos Health, Inc., operates as an integrated biopharmaceutical solutions company. The company operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in Phase I to IV of clinical development. This segment offers individual services, including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication; and consulting services. Its customers include companies in the biopharmaceutical, biotechnology, and medical device industries. It operates in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company has a strategic partnership with uMotif Limited to deliver patient-centric eClinical platform. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina. As of September 28, 2023, Syneos Health, Inc. was taken private.